Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01862510 · ClinicalTrials.gov registry record
Detection of Celiac Disease in Patients With Hypothyroidism
A clinical trial of Celiac Disease and Hypothyroidism, sponsored by University of Vermont.
- Completed
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT01862510: Completed study of Celiac Disease and Hypothyroidism, sponsored by University of Vermont.
NCT01862510 is a study of Celiac Disease and Hypothyroidism that has completed, run by University of Vermont. The registered enrollment target is 500 participants, below the 1,959-participant average among 24 other Celiac Disease trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01862510, a study of Celiac Disease and Hypothyroidism, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The study evaluates whether hypothyroid patients requiring elevated doses of levothyroxine to maintain a euthyroid state are at increased risk of having celiac disease. It also attempts to determine if there is a threshold level of levothyroxine needed to maintain a euthyroid state in patients with hypothyroidism that should prompt serologic testing for celiac disease.
Conditions Studied
Study Locations (1)
Vermont
- Fletcher Allen Health Care - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2012-03 |
| Est. Completion | 2014-12 |
What the finished NCT01862510 record still lists
NCT01862510 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,959-participant average among 24 other Celiac Disease trials with a reported enrollment target (74% lower).
The record links to 4 conditions, with Celiac Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01862510 reports a single indexed study location in Vermont.
Frequently Asked Questions
What is clinical trial NCT01862510 about?
NCT01862510 is a clinical study titled "Detection of Celiac Disease in Patients With Hypothyroidism". The study evaluates whether hypothyroid patients requiring elevated doses of levothyroxine to maintain a euthyroid state are at increased risk of having celiac disease. It also attempts to determine if there is a threshold level of levothyroxine needed to maintain a euthyroid state in patients with ...
What is the current status of trial NCT01862510?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2012-03. Estimated completion is 2014-12.
What conditions does trial NCT01862510 study?
This clinical trial studies the following conditions: Celiac Disease, Hypothyroidism, Malabsorption, Celiac Sprue.
Who is sponsoring clinical trial NCT01862510?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01862510 being conducted?
This trial has 1 study location across Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Celiac Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01862510's enrollment target sits among peer trials
500 4th of 24 higher than 20 of 24 other Celiac Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Celiac Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tissue Destruction and Healing in Celiac Disease
RECRUITING · NA
-
Celiac Disease Genomic Environmental Microbiome and Metabolomic Study
RECRUITING
-
A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease
RECRUITING · Phase 1
-
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
RECRUITING
-
Immune Responses to Gluten
RECRUITING · NA
-
Double Blind, Placebo-controlled Trial to Establish Safety and Efficacy of Ritlecitinib in Celiac Disease Patients in Remission
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia